ArticleScientific reports2025
Development and validation of the risk stratification based on deep learning and radiomics to predict survival of advanced cervical cancer.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Unsupervised risk factor identification across cancer types and data modalities via explainable artificial intelligence.NPJ digital medicine · 2026Article
- Radiomics and artificial intelligence in precision radiotherapy for cervical cancer: a narrative review.Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Advanced cervical cancer (aCC) is associated with a poor prognosis. This study aimed to develop and validate a deep learning-based risk stratification model to predict overall survival in aCC patients using pre-treatment CT images. A total of 396 patients with aCC were retrospectively enrolled and randomly allocated into training (n = 198) and validation (n = 198) cohorts. A deep learning model integrating a Vision Transformer (ViT) for feature extraction and a Recurrent Neural Network (RNN) for sequence modeling was developed to generate a prognostic radiomic signature (Rad-score) from baseline CT scans. The Rad-score was incorporated into a Cox proportional hazards model alongside clinical variables to construct an integrative nomogram. The model's performance was evaluated using the concordance index (C-index), time-dependent receiver operating characteristic (ROC) analysis, calibration curves, and decision curve analysis (DCA). Multivariate Cox regression identified the Rad-score as a strong independent prognostic factor (Hazard Ratio [HR] = 4.06, 95% confidence interval [CI]: 2.46-6.70, p < 0.001). The integrative nomogram achieved C-indexes of 0.784 (95% CI: 0.733-0.835) and 0.726 (95% CI: 0.677-0.785) in the training and validation cohorts, respectively. Calibration and DCA curves indicated good clinical utility. Kaplan-Meier analysis confirmed that the model-based risk stratification significantly discriminated between high- and low-risk patients (p < 0.001). The proposed deep learning-based nomogram offers a non-invasive and reproducible tool for predicting survival in aCC patients. It shows potential for assisting clinicians in making personalized treatment decisions and warrants further validation in prospective, multi-center studies before widespread clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.